NSTG
NanoString Technologies specializes in spatial biology and multiomics, offering platforms for spatial transcriptomics, proteomics, and genomics to enable tissue-wide analysis and biomarker discovery. Its GeoMx Digital Spatial Profiler, CosMx Spatial Molecular Imager, and AtoMx Spatial Informatics Platform support high-plex, single-cell imaging and spatial data analysis across FFPE and fresh tissue samples, with a focus on accelerating drug development and translational research globally. The company operates primarily in the United States, with a global customer base in life sciences and biomedical research.
No recent news for this company.
No recent deals for this company.